Our findings demonstrate that quinacrine plays a crucial role in regulating the intracellular arginine pool by transcriptionally downregulating the arginine transporter SLC3A2, resulting in the inhibition of PTCL cell growth. The gene discussed is SLC3A2; the disease is mature T-cell and NK-cell non-Hodgkin lymphoma.